Seeking Alpha

Poniard Pharmaecuticals, Inc. (PARD)

()

News & PR
Market Currents

Buzz
Twitter: PARD

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Tuesday Options Recap: Put-Call Ratio Leaders

Dec 15 • Frederic Ruffy • Comment!
Options Trader: Monday Market Movement

Dec 7 • Philip Davis • 5 Comments
Two Week Wrap-Up: Trading Both Ends of Our Range

Dec 7 • Philip Davis • Comment!
Azimuth Opportunity Bets on Poniard's Survival

Nov 25 • Ivan Mutaftchiev • Comment!
Weak Weekly Market Wrap-Up: Primed for a Correction

Nov 23 • Philip Davis • 5 Comments
Poniard Pharmaceuticals' Gamble Doesn't Pay Off

Nov 18 • EP Vantage • 2 Comments
Tuesday Options Recap

Nov 17 • Frederic Ruffy • Comment!
BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI

Nov 17 • Mike Havrilla • 2 Comments
Monday Options Recap

Nov 16 • Frederic Ruffy • 1 Comment
Options Trader Friday Outlook: Churn Baby Churn

Oct 23 • Philip Davis • Comment!
Monday Options Recap

Oct 19 • Frederic Ruffy • Comment!
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

Sep 20 • Justin M. Hall • 3 Comments
Wednesday's Options Recap

Sep 16 • Frederic Ruffy • 5 Comments
Options Trader Friday Outlook: Up, Up and Away

Sep 11 • Philip Davis • 11 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Sep 11 • Justin M. Hall • 23 Comments
Options Trader: August Retrospective

Aug 29 • Philip Davis • Comment!
Biotech Dealmaking Takes a Summer Breather

Aug 23 • The Burrill Report • Comment!
Friday Options Recap

Jul 31 • Frederic Ruffy • 2 Comments
FDA Calendar: 2H09 Binary Event Trades

Jul 27 • Mike Havrilla • 3 Comments
Big Lineup of Healthcare Stocks Crack the Russell 3000 Index

Jul 1 • M. E. Garza • Comment!
Molecular Insight Pharmaceuticals: Two Promising Candidates to Battle Prostate Cancer

Jun 19 • Michael Becker • 6 Comments
Healthcare Stocks Sluggish as Some Say Recent Rally Is Over

Jun 16 • M. E. Garza • Comment!
Biotech Stocks and the ASCO-Effect

Jun 1 • Michael Becker • 2 Comments
Pending Clinical Trial Results: Ten Extreme Trades

May 14 • Mike Havrilla • 8 Comments
Tracking Cancer Diagnostic and Therapeutic Stocks

Apr 13 • Mike Havrilla • 6 Comments
Rigel Pharmaceuticals: Biotech Crisis or Opportunity?

Nov 10, 2008 • Ohad Hammer • 2 Comments
'When There's Blood in the Streets', Buy Biotech Stocks

Oct 10, 2008 • Ohad Hammer • 13 Comments
Poniard Pharmaceuticals: Platinum Rediscovered (Part II)

Jun 24, 2008 • Ohad Hammer • 5 Comments
Poniard Pharmaceuticals: Platinum Rediscovered (Part I)

May 30, 2008 • Ohad Hammer • Comment!
Poniard Pharmaceuticals' Promising Pipeline

Feb 26, 2008 • The Wall Street Transcript • Comment!
Cancer Stocks Hammered Once Again

Jun 26, 2007 • Alan Brochstein • 7 Comments
Cancer Stocks Slide Again

Jun 18, 2007 • Alan Brochstein • 1 Comment
Cancer Stocks Plunge Following ASCO Meeting

Jun 11, 2007 • Alan Brochstein • 3 Comments
Cancer Stocks Soar With Annual ASCO Meeting

Jun 4, 2007 • Alan Brochstein • 1 Comment
Cancer Stocks on the Go: Winners and Losers

May 29, 2007 • Alan Brochstein • 3 Comments
Florida: The Next Biotech Hot Spot?

Mar 1, 2007 • H.S. Ayoub • 3 Comments

Poniard Pharmaecuticals, Inc. (PARD)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers